Haylex Laboratories Inc. — Form D

Haylex Laboratories Inc. of KERRVILLE, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-21. The offering totals $1.5M, of which $50K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-04-21
• Form: D
• Accession: 0002124719-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.5M
• Amount sold: $50K
• Remaining: $1.4M
• Investors: 1
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-581307

Issuer

• Name: Haylex Laboratories Inc.
• CIK: 0002124719
• Entity type: Corporation
• Jurisdiction: TEXAS
• Address: 2317 TRAILS END, KERRVILLE, TX, 78028
• Phone: 830-431-2759

Officers, directors & promoters (1)

More

• CIK 2124719 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search